Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L van Doorn

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.
RNA (New York, N.Y.)|November 23, 2006
Heterodimerization regulates RNase MRP/RNase P association, localization, and expression of Rpp20 and Rpp25Tim J M Welting, Florence M A Peters, Sanne M M Hensen, et al.
British Journal of Cancer|November 21, 2007
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumoursF A L M Eskens, C H Mom, A S T Planting, et al.
Clinical and Translational Science|April 4, 2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-GlucuronideS Bins, L van Doorn, M A Phelps, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2009
Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumoursJ J E M Kitzen, M J A de Jonge, C H J Lamers, et al.
European Heart Journal. Digital Health|March 20, 2024
Detection of acute coronary occlusion with a novel mobile electrocardiogram device: a pilot studyAlejandra Zepeda-Echavarria, Rutger R van de Leur, Melle Vessies, et al.
BMC Cancer|April 7, 2019
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trialF E Buisman, M Y V Homs, D J Grünhagen, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.
RNA (New York, N.Y.)|November 23, 2006
Heterodimerization regulates RNase MRP/RNase P association, localization, and expression of Rpp20 and Rpp25Tim J M Welting, Florence M A Peters, Sanne M M Hensen, et al.
British Journal of Cancer|November 21, 2007
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumoursF A L M Eskens, C H Mom, A S T Planting, et al.
Clinical and Translational Science|April 4, 2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-GlucuronideS Bins, L van Doorn, M A Phelps, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2009
Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumoursJ J E M Kitzen, M J A de Jonge, C H J Lamers, et al.
European Heart Journal. Digital Health|March 20, 2024
Detection of acute coronary occlusion with a novel mobile electrocardiogram device: a pilot studyAlejandra Zepeda-Echavarria, Rutger R van de Leur, Melle Vessies, et al.
BMC Cancer|April 7, 2019
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trialF E Buisman, M Y V Homs, D J Grünhagen, et al.
Pageof 3